Reversible inhibition of type B monoamine oxidase. Theoretical study of model diazo heterocylic compound
- 30 September 1997
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 32 (9) , 721-730
- https://doi.org/10.1016/s0223-5234(97)88914-3
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Transformation of heterocyclic reversible monoamine oxidase-B inactivators into irreversible inactivators by N-methylationJournal of Medicinal Chemistry, 1993
- Synthesis and Monoamine Oxidase Inhibitory Activity of 3‐Substituted 5H‐Indeno[1,2‐c]pyridazinesHelvetica Chimica Acta, 1993
- Transformation of monoamine oxidase-B primary amine substrates into time-dependent inhibitors. Tertiary amine homologs of primary amine substratesJournal of Medicinal Chemistry, 1993
- 5-[4-(Benzyloxy)phenyl]-1,3,4-oxadiazol-2(3H)-one derivatives and related analogs: new reversible, highly potent, and selective monoamine oxidase type B inhibitorsJournal of Medicinal Chemistry, 1993
- Aliphatic propargylamines: potent, selective, irreversible monoamine oxidase B inhibitorsJournal of Medicinal Chemistry, 1992
- MDL-72,974ADrugs of the Future, 1991
- 5-(Aminomethyl)-3-aryl-2-oxazolidinones. A novel class of mechanism-based inactivators of monoamine oxidase BJournal of the American Chemical Society, 1990
- Model studies for the mechanism of inactivation of monoamine oxidase by 5-(aminomethyl)-3-aryl-2-oxazolidinonesJournal of the American Chemical Society, 1989
- Binding of [3H]Ro 16-6491, a Reversible Inhibitor of Monoamine Oxidase Type B, to Human Brain Mitochondria and Platelet MembranesJournal of Neurochemistry, 1986
- Electronic Population Analysis on LCAO–MO Molecular Wave Functions. IThe Journal of Chemical Physics, 1955